Erik Forsberg, PhD

Erik Forsberg, PhD is responsible for RMS’ science initiatives, and is focusing on accelerating the development a RMS’ novel cell culturing media and other products, targeted at diabetes. Dr. Forsberg previously was the Executive Director of WiCell Research Institute where he coordinated WiCell’s interactions with the University of Wisconsin and the Wisconsin Alumni Research Foundation (WARF). He also led efforts to contract with multiple external clients to expand and characterize human pluripotent stem cells for use in research and the development of new cell therapies.

Prior to WiCell, Dr. Forsberg was Senior Director of Scientific Development at Pharming NV where he led efforts to achieve FDA Orphan Drug designation for use of recombinant human fibrinogen (rhFib) produced in the milk of transgenic cows for treating fibrinogen deficiency diseases. He also led negotiations to establish an agreement with a major pharmaceutical company for preclinical studies using rhFib, which was shown to reverse major hemorrhage events in animal models.

Simultaneous with his appointments at Pharming and WiCell, Dr. Forsberg maintained a part-time appointment in the Department of Surgery at the UW-Madison and advised an affiliated UW-Madison spinout company that is developing a candidate gene therapy treatment for type 1 diabetes.
Dr. Forsberg transitioned to Pharming as a result of efforts he led at Infigen, Inc. to develop the genetically engineered cows supplied to Pharming. As Vice President at Infigen, he managed the development of genetically modified cloned animals for therapeutic protein production, for use in xenotransplantation studies, and for use as animal models of disease. He also was responsible for partner relations, intellectual property management, quality assurance implementation, and grant submission.

Prior to Infigen, Dr. Forsberg was an assistant professor in the Department of Physiology at the University of Wisconsin where his research resulted in six publications in noteworthy journals and where he mentored three graduate students who received their Ph.D.’s under his guidance.
Following his graduate studies, Dr. Forsberg was a Senior Staff Fellow in the Laboratory of Cell Biology and Genetics at the National Institutes of Health where he studied signal transduction mechanisms in adrenal endocrine cells and vascular endothelial cells.

Dr. Forsberg graduated magna cum laude from Kalamazoo College and obtained his Ph.D. at the University of Chicago in the Department of Pharmacological and Physiological Sciences.

Erik Forsberg

Management Team
Back to Top